Congenital and developmental myasthenia

G6_CONDEVMYA

Myasthenia gravis: Myasthenia gravis (MG) is a rare, clinically heterogeneous, autoimmune disorder of the neuromuscular junction characterized by fatigable weakness of voluntary muscles.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 G70.20, G70.21, G70.28

Hospital discharge: ICD-9 $!$

Hospital discharge: ICD-8 $!$

Cause of death: ICD-10 G70.20, G70.21, G70.28

Cause of death: ICD-9 $!$

Cause of death: ICD-8 $!$

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

Check minimum number of events None

Include endpoints None

G6_CONDEVMYA

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Congenital and developmental myasthenia based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	18	11	7
Unadjusted prevalence (%)	0.01	0.01	0.01
Mean age at first event (years)	54.20	44.50	69.43

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: G6_CONDEVMYA – Congenital and developmental myasthenia
GWS hits:

Survival analyses between endpoints

↥

Plot

before Congenital and developmental myasthenia
after Congenital and developmental myasthenia

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Congenital and developmental myasthenia

↥